Biocracked
Approach: conceptual metaphor. Palette: bold color field.

A single ripe, glossy red tomato-colored apple sits at the center of a saturated mustard-yellow seamless backdrop, with a neat row of five identical white capsules lined up beside it on the same surface. The apple is the clear winner of the frame. One capsule has rolled slightly away, cracked open and spilling a tiny pile of pale powder. Shot at a low three-quarter angle with a shallow depth of field, so the back capsules blur softly. Lighting is a large, soft key light from the upper left, giving crisp but gentle shadows with warm yellow bounce. A thin sprig of electric green (#00e676) leaves rises from the apple stem as the only green accent. Mood: confident, playful and skeptical, a clean verdict that real food outweighs pills. No text or labels.
Longevity

Compléments contre les cellules zombies ? 27 essais humains montrent que le régime l'emporte sur les pilules

Nova Chen · · 4 min read

Plenty of supplement labels promise to "clear zombie cells." A new systematic review asked what human trials actually show, and the answer is less flattering to the pill aisle than the marketing suggests.

Researchers at the European Research Institute for the Biology of Ageing (ERIBA) in Groningen, including senescence researcher Marco Demaria, pooled the human interventional evidence on nutrition and cellular senescence. The review, published in Ageing Research Reviews, covers 29 articles describing 27 trials and 3,811 participants. Searches ran through September 2024.

The headline: calorie restriction produced the most consistent signal. Supplements were a distant, murkier second. The classic "senescent cell" markers mostly didn't budge.

First, what are "zombie cells"?

Senescent cells have permanently stopped dividing but don't die. They also release a mix of inflammatory and tissue-remodeling molecules known as the senescence-associated secretory phenotype, or SASP. Research has linked this to aging biology, which is why "senolytic" and "anti-senescence" products are so popular.

The catch is measurement. You can't easily count senescent cells in a living person, so trials rely on stand-in biomarkers. The review looked at several kinds:

  • Cell-cycle arrest markers such as CDKN2A/p16 and CDKN1A/p21
  • DNA damage markers
  • Telomere length
  • Transcriptomic (gene‑expression) signatures
  • SASP‑related factors, mostly circulating inflammatory molecules

Calorie restriction took the lead

Among all nutritional strategies, calorie restriction produced the most recurrent reductions in circulating inflammatory and secretory factors commonly found in SASP panels. It also reduced senescence‑associated transcriptomic signatures.

That is the strongest result in the review, and it matches what many aging researchers already suspected. Eating less appears to move senescence‑linked inflammatory profiles in humans in a way that no supplement matched here.

The reductions were seen in SASP‑type markers, not in a direct count of senescent cells. That distinction matters, as the section on limitations below explains.

The markers people love to cite? Mostly flat

Two of the most widely quoted aging readouts did poorly:

  • p16 and p21, the classical cell‑cycle arrest markers, were largely unchanged or highly variable across studies.
  • Telomere length was also largely unchanged or highly variable.

If a product claims to "lengthen telomeres" or "lower p16" through diet or supplements, this review gives it little support in human intervention trials.

Metformin and rapamycin: it depends

The review also examined calorie restriction mimetics, drugs and compounds that act on similar pathways. Metformin and rapamycin showed context‑dependent effects, most evident under metabolic or physiological stress.

That suggests they may matter most in people who already have a metabolic problem or a physiological challenge, not as a universal anti‑aging switch for healthy people. Both are prescription drugs, so this is a conversation for a physician, not a shopping cart.

Omega‑3: best supplement signal, with caveats

Of the dietary supplements, n‑3 polyunsaturated fatty acids (omega‑3s) looked most promising. They may modulate selected inflammatory and SASP‑related circulating markers.

The authors were careful, though. They describe the supplement evidence overall as limited and heterogeneous. That means small or varied studies, different populations, and different markers, not a clear verdict.

Practical takeaways

What the evidence supports

  • If you want to influence senescence‑linked inflammatory signals, calorie restriction has the strongest human support in this review. The paper doesn't prescribe a specific protocol, so work out a safe approach with a clinician.
  • If you're going to try one supplement for this reason, omega‑3 has the best support. It is usually sold as fish oil, krill oil, or algal oil (a vegan option) containing EPA and DHA.
  • The review doesn't establish an optimal omega‑3 dose or form for senescence. Check the EPA and DHA content on the label, not just the total oil, and follow your clinician's guidance.

Who this might suit

  • People already considering weight management or dietary changes, who can treat calorie restriction as one of the better‑supported options.
  • People who already have a reason to take omega‑3 and want a modest, low‑hype addition.

Who should skip or be cautious

  • Anyone expecting a pill to "clear" senescent cells. This review doesn't show that.
  • People who are underweight, pregnant, have a history of disordered eating, or have medical conditions. Calorie restriction isn't appropriate for everyone without supervision.
  • People on blood thinners or with other medical conditions, who should talk to a doctor before starting high‑dose fish oil.
  • Anyone thinking of self‑medicating with metformin or rapamycin. They are prescription drugs with context‑dependent effects, and this review is not a green light.

The big caveat: these are signals, not proof

The authors stress that SASP factors and circulating cytokines are heterogeneous and not specific to senescent cells. Inflammation markers can fall for many reasons that have nothing to do with senescence, such as weight loss or lower general inflammation.

So the findings show possible modulation of senescence‑associated markers, not definitive reductions in the number of senescent cells. The nutritional interventions appeared to affect inflammatory and secretory profiles more than the markers tied directly to how many senescent cells are present.

This review is also a synthesis of human trials, so its conclusions aren't animal or lab findings. But many of the claims behind "senolytic" supplements come from cell and rodent work, which the review doesn't evaluate.

What comes next

The authors call for multi‑marker, functionally relevant endpoints in future clinical studies. In plain terms: measure several things at once and tie them to real health outcomes, rather than relying on one convenient blood marker.

Bottom line

No supplement in this review has been shown to clear zombie cells in humans. Calorie restriction has the best‑supported effect on senescence‑linked inflammatory signals. Omega‑3 is the most promising supplement, with limited and uneven evidence. Telomere and p16 claims don't hold up in these trials.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: macro science. Palette: bold color field (violet).

Extreme close-up of fisetin crystals, a small cluster of pale yellow needle-like flavonoid crystals with translucent, faceted edges, resting on a smooth glossy deep violet surface. The camera sits low at a shallow three-quarter angle with a very shallow depth of field, so the front crystals are razor sharp and the rest dissolves into soft magenta-violet blur. Lighting is a single crisp, slightly warm studio key from upper left that makes the crystal edges glow and throws long soft shadows across the violet. A few tiny electric green (#00e676) specks of reflected light catch on the crystal tips. The mood is precise, curious and quietly promising, like a sample under inspection, with plenty of clear violet space on the right side of the frame.
longevity

Fisetine, un sénolytique, prolonge la durée de vie des souris : la preuve chez l’homme manque toujours

BY HELIX WARD ·

La fisétine, flavonoïde végétal, s’est imposée comme le sénolytique le plus puissant parmi dix composés dans l’étude largement citée de 2018 publiée dans *EBioMedicine*. Chez les souris âgées, un traitement administré tard dans la vie a réduit les marqueurs de sénescence, atténué les pathologies liées à l’âge et prolongé l’espérance de vie médiane et maximale. Le hic, c’est que ces résultats proviennent uniquement d’études sur des souris et de travaux *in vitro* ; aucun essai clinique humain complet n’a encore confirmé ces effets. Cet article détaille les découvertes, leur portée en termes de dosage, et les points d’attention lorsqu’émergeront les études humaines.

**Approach: Conceptual metaphor. Palette: B, Warm.**

A close, slightly high three-quarter view of a single weathered hemp rope stretched horizontally across the frame, shot at a shallow depth of field. On the left the rope is thick and tightly twisted. On the right it has frayed down to a few thin strands, with a short, neat whipping of bright electric green thread binding the rope just where the fraying stops. Golden-hour sunlight enters low from the left and picks out each individual fiber in honey and copper tones. Soft amber shadows fall across a blurred, sun-warmed wooden dock in the background. The mood is quiet and cautiously hopeful, suggesting something worn down slowly but partly held in place. The image is photorealistic and has no text.
longevity

Vitamine D3 préserve 140 paires de bases des télomères dans un essai randomisé de 4 ans

BY DR. SYNAPSE ·

Un vaste essai randomisé, en double‑aveugle, à contrôle placebo, a montré que quatre ans de supplémentation en vitamine D3 ralentissent la perte de longueur des télomères d’environ 140 paires de bases. Les données proviennent de l’étude VITAL, menée chez des adultes américains plus âgés prenant 2 000 UI/jour. L’effet est modestement significatif (p = 0,039) ; la longueur des télomères reste cependant un biomarqueur de substitution, et non la preuve d’une espérance de vie accrue. Les oméga‑3, quant à eux, n’ont montré aucun effet sur les télomères dans cet essai. Voici ce que les chiffres révèlent, leurs limites, et comment exploiter ce résultat de façon sensée.

A bright, airy editorial still life on a pale warm-white linen surface, shot from a slightly elevated three-quarter angle in soft natural window light. On the left, a small hand-thrown ceramic dish in matte oatmeal glaze holds several translucent golden-amber omega-3 softgel capsules, catching the light like tiny honey droplets. Next to it sits a smaller dish with a few pale yellow vitamin D capsules. Beside them, a halved fresh salmon fillet in coral-pink with delicate white marbling rests on a slate-gray stone board, with a sprig of dill and a thin lemon wedge. A few walnuts and a small glass bottle of olive oil lend a quiet Mediterranean feel.

On the right side of the frame, a pair of lightweight sage-green resistance bands and a single brushed-steel dumbbell in a muted tone rest on a folded cream towel, hinting at a home strength routine. Behind them, a vintage brass pocket watch lies open, its face softly out of focus, with a thin ribbon of cream fabric curling beside it to suggest the passage of time. A sparse, elegant sprig of dried eucalyptus arches across the top corner.

The palette is calm and modern: warm cream, soft sage, muted coral, honey gold, and stone gray, with gentle diffused shadows and a shallow depth of field. The background fades into a creamy blur with a hint of a sunlit window and sheer curtain. The composition leaves generous negative space across the upper left and center for headline text. The overall mood is clean, trustworthy, and contemporary, like a premium health and science journal feature, with subtle film-like grain, natural textures, and minimalist styling.
longevity

L'oméga‑3 ralentit le vieillissement biologique d'environ trois mois sur trois ans, selon un essai contrôlé

BY DR. SYNAPSE ·

Un essai randomisé mené auprès de 777 adultes de 70 ans et plus a montré qu’un gramme quotidien d’oméga‑3 ralentissait plusieurs horloges épigénétiques d’environ trois mois sur trois ans. Lorsque l’oméga‑3 était combiné à de la vitamine D (2 000 UI/j) et à un programme simple de musculation à domicile, les effets semblaient s’additionner sur l’horloge PhenoAge. L’effet reste modeste, l’analyse a été réalisée a posteriori et les horloges épigénétiques ne sont que des marqueurs indirects, pas une preuve d’allongement de la vie. Ce résumé détaille les chiffres, les limites et les doses pratiques, ainsi que les personnes qui devraient d’abord consulter un médecin.

A wide, softly lit editorial still life on a pale warm-gray stone surface, shot from a slightly elevated three-quarter angle. On the left, a small cluster of fresh yellow-gold onions with papery skins, one cut in half to show its pale concentric layers, sits beside a few dusty-red capers and a sprig of dill. These are natural quercetin sources and read as quiet botanical details. In the center, a minimalist glass apothecary dish holds a few small, round, off-white tablets. Beside it, a slim amber glass vial lies on its side with a plain unlabeled cap.

On the right, a neatly arranged clinical element: a vintage-style wooden-handled stopwatch and a crisp paper stride-length measuring tape curled in a loose spiral, hinting at the 6-minute walk test and gait speed measures. Behind these, a softly out-of-focus wall of pale sage green with a subtle shadow of a window frame cast diagonally across it. A single translucent anatomical line drawing of lungs, rendered in fine charcoal ink on cream paper, leans against the wall, its delicate branching bronchi echoing the veining of a nearby green leaf.

Lighting is soft morning daylight from the upper left, creating gentle long shadows and a calm, thoughtful mood. The palette is muted and modern: butter yellow, sage, cream, warm gray, with small accents of terracotta and amber. Shallow depth of field keeps the tablets and onion sharp while the background melts into a creamy blur. Generous negative space across the upper right makes room for headline overlay. The composition feels like a contemporary science journal or wellness-research magazine cover: clean, tactile, restrained, with subtle film grain and natural color grading. No text, no logos, no people, no futuristic elements.
longevity

Les premiers humains à recevoir du dasatinib + quercétine : ce qu’un essai pilote chez 14 patients atteints de fibrose pulmonaire idiopathique a montré (et n’a pas montré)

BY DR. SYNAPSE ·

En 2019, des chercheurs ont publié la toute première utilisation chez l’homme de la combinaison sénolytique dasatinib + quercétine, chez 14 patients atteints de fibrose pulmonaire idiopathique (FPI). Après trois semaines de dosage intermittent, les participants ont présenté des améliorations significatives de la distance de marche de 6 minutes, de la vitesse de marche et du temps de lever d’une chaise, alors que la fonction pulmonaire est restée stable. L’étude a également recensé un événement indésirable grave ainsi que de fréquentes atteintes respiratoires, cutanées et gastro‑intestinale. Il s’agissait toutefois d’une étude ouverte, non contrôlée, d’un médicament anticancéreux couplé à une dose pharmacologique de flavonoïde, et non d’un protocole de supplémentation. Voici ce que l’essai a réellement testé, ce qu’il a observé et comment l’interpréter de façon critique.

This page is available in